AAM
SGMO

Advisors Asset Management’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Advisors Asset Management’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-11,871
Closed -$99K – 1549
2019
Q4 		$99K Sell
11,871
-6,121
-34% -$56.3K ﹤0.01% 1320
2019
Q3 		$163K Sell
17,992
-415
-2% -$4.66K ﹤0.01% 1223
2019
Q2 		$198K Sell
18,407
-457
-2% -$4.86K ﹤0.01% 1192
2019
Q1 		$180K Sell
18,864
-559
-3% -$5.71K ﹤0.01% 1384
2018
Q4 		$223K Sell
19,423
-1,144
-6% -$14.2K ﹤0.01% 1178
2018
Q3 		$349K Sell
20,567
-620
-3% -$9.42K 0.01% 1134
2018
Q2 		$301K Buy
21,187
+15,960
+305% +$265K 0.01% 1160
2018
Q1 		$125K Buy
5,227
+4,271
+447% +$91.3K ﹤0.01% 1295
2017
Q4 		$16K Buy
+956
New +$14.2K ﹤0.01% 1455

Other funds holding SGMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Advisors Asset Management's SGMO Position: Q1 2020 in Review

Advisors Asset Management sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q1 2020, closing a stake of 11,871 shares — an estimated $99K sold.

Advisors Asset Management first reported a position in SGMO in Q4 2017 and held it in 9 quarters. The position peaked at $349K in Q3 2018. 190 funds tracked by Wall St. Rank hold SGMO as of Q1 2020.

  • Advisors Asset Management reported no remaining SANGAMO THERAPEUTICS INC position as of Q1 2020 after selling out during the quarter.
  • Advisors Asset Management sold 11,871 SANGAMO THERAPEUTICS INC shares in Q1 2020, an estimated $99K.
  • Advisors Asset Management first reported a position in SANGAMO THERAPEUTICS INC in Q4 2017 and held it in 9 quarters.
  • Advisors Asset Management's SANGAMO THERAPEUTICS INC position peaked at $349K in Q3 2018.
  • 190 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q1 2020.

Based on Advisors Asset Management's 13F filing for Q1 2020, filed 15 May 2020.